Bio-Rad completed the acquisition of Celsee.

Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, completed the acquisition of Celsee, a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Financial terms were not disclosed. “We are pleased to have Celsee join Bio-Rad. Their innovative products and technologies will extend our reach into the rapidly growing world of precision medicine and single-cell analysis, both of which offer enhanced insight into disease, diagnosis, and treatment,” Norman Schwartz, Bio-Rad President and CEO.